Two year results in a randomized, double-blind, placebo-controlled study of odanacatib (MK-822) in postmenopausal women with low bone mineral density
No Thumbnail Available
Authors
Eisman, J. A.
Recker, R. R.
McClung, M.
Bone, H.
Roux, C.
Verbruggen, N.
Hustad, C. M.
DaSilva, C.
Santora, A.
Ince, A.
Issue Date
2009
Volume
44
Issue
Type
Journal Article
Language
Keywords
Alternative Title
Abstract
Description
Citation
Eisman, J. A.; Recker, R. R.; McClung, M.; Bone, H.; Roux, C.; Verbruggen, N.; Hustad, C. M.; DaSilva, C.; Santora, A.; Ince, A. Two year results in a randomized, double-blind, placebo-controlled study of odanacatib (MK-822) in postmenopausal women with low bone mineral density. Bone. 2009, 05/02. 44:S103-S104.
Publisher
License
Journal
Volume
Issue
PubMed ID
DOI
Identifier
ISSN
8756-3282
1873-2763
1873-2763
